(Q45262069)

11 December 2017

Peptide-primed CD4+ cells and malaria sporozoites (English)

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

3 November 2022

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

3 November 2022

author name string

Rénia L

3

1 reference

11 December 2017

G. Del Giudice

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

D. Grillot

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

L. Rénia

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

I. Müller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

G. Corradin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

J. A. Louis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

D. Mazier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

P. H. Lambert

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1704350

3 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1704350

3 November 2022

publication date

1 August 1990

1 reference

full work available at URL

11 December 2017

https://api.elsevier.com/content/article/PII:0165247890900925?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

https://api.elsevier.com/content/article/PII:0165247890900925?httpAccept=text/plain

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

3 November 2022

1 reference

11 December 2017

25

1 reference

11 December 2017

1-3

1 reference

11 December 2017

59-63

1 reference

Rationale for the development of an engineered sporozoite malaria vaccine

11 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine

3 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite protein

3 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.

3 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Epitopes recognized by human T lymphocytes on malaria circumsporozoite protein.

3 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.

3 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Cytotoxic T cells specific for the circumsporozoite protein of plasmodium falciparum

3 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes

3 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

3 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

3 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Immunology: The ins and outs of antigen processing and presentations

3 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Circumsporozoite protein of Plasmodium berghei: gene cloning and identification of the immunodominant epitopes

3 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Plasmodium berghei: cloning of the circumsporozoite protein gene

3 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Variation among circumsporozoite protein genes from rodent malarias.

3 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Human T cells recognize polymorphic and non-polymorphic regions of the Plasmodium falciparum circumsporozoite protein.

3 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei

3 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

3 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

MHC control of CD4+ T cell subset activation

3 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon.

3 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

3 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

3 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

T-cell responses and immunity to experimental infection with leishmania major

3 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Are MHC class II-restricted cytotoxic T lymphocytes important?

3 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

3 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

3 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

Identification of two promiscuous T cell epitopes from tetanus toxin

3 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.

3 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

A novel and simple procedure for determining T cell epitopes in protein antigens

3 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0165-2478(90)90092-5

3 November 2022

Identifiers

1 reference

11 December 2017

1 reference